Skip to main content
. 2015 Nov 25;2015(11):CD010576. doi: 10.1002/14651858.CD010576.pub2

Jarhult 2005.

Methods Type of study: randomised controlled clinical trial
Allocation: 1:1
Intervention model: parallel group superiority design
Masking: no blinding of patients or personnel
Primary purpose: treatment of Graves' disease
Participants Condition: Graves' disease
Enrolment: 44 in total
Inclusion criteria:
1. Diagnosis of Graves disease
2. Preop treatment with antithyroid drugs for at least 3 months
3. Euthyroidism at time of operation
4. Active Graves opthalmopathy of at least moderate degree
Exclusion criteria:
1. Previous thyroid or parathyroid surgery
2. Previous treatment with radioiodine
3. Elevation of TSH value more than 200% above normal during antithyroid treatment and within three months prior to surgery
Diagnostic criteria: Graves' disease with ophthalmopathy, TFT, TSH antibodies and histological diagnosis based on tissue obtained form surgery.
Interventions Number of study centres: 10
Treatment before study: preoperative treatment with antithyroid medications for at least 3 months.
Titration period: none
Intervention(s): total thyroidectomy (complete macroscopic removal of thyroid tissue)
Comparator(s): subtotal thyroidectomy (either subtotal bilateral resection or hemithyroidectomy plus unilateral subtotal resection leaving no more than a total of 4 g of remnant tissue)
Outcomes Primary outcome(s):
1. Change in Graves' ophthalmopathy
Secondary outcome(s):
2. Permanent hypoparathyroidism
3. Recurrent laryngeal nerve palsy
Other outcome(s): TRAb measurements
Study details Run‐in period: none
Study terminated before regular end (for benefit/because of adverse events): no
Study start date: not stated
Study completion date: not stated
Publication details Language of publication: English
Funding: non‐commercial funding
Publication status: peer‐reviewed journal, full article
Stated aim for study This study enrolled patients with moderate‐severe endocrine ophthalmopathy and discussed long term results of a prospective, randomised trial of treatment with total or subtotal thyroidectomy
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote from publication: "Forty‐four patients with Graves' disease (GD) and a moderate‐severe Grave's ophthalmopathy were randomly allocated to undergo total or subtotal thyroidectomy"
Comment: method of randomisation not specified; took place after consent for surgery
Allocation concealment (selection bias) Unclear risk Comment: not stated whether allocation concealment took place
Blinding of participants and personnel (performance bias) 
 Objective outcomes High risk Quote from publication: "The design of the study left decisions about the surgical and postoperative care to the attending surgeon"
Comment: surgeon could not be blinded to group allocation; note that multiple centres were involved in recruitment for the study
Blinding of participants and personnel (performance bias) 
 Subjective outcomes High risk Comment: not stated that patients were blinded to the intervention
Blinding of outcome assessment (detection bias) 
 Objective outcomes Low risk Quote from publication: "the follow up consisted of ... biochemical analyses of TSH, free T3 and free T4, TRAB titre and calcium"
Comment: evaluation of TRAb, thyroid function and calcium: laboratory standard tests
Blinding of outcome assessment (detection bias) 
 Subjective outcomes Low risk Quote from publication: "Evaluation of eye disease activity was carried out by an ophthalmologist... the ophthalmologist was not informed of the type of thyroid surgery performed"
Comment: ophthalmopathy ‐ assessed by blinded ophthalmologist
Incomplete outcome data (attrition bias) 
 Objective outcomes Low risk Quote from publication: "one patient in the subtotal resection group... refused to come for evaluation after the first two post operative check ups"
Comment: one patient lost to follow‐up out of 44; all other outcomes reported
Incomplete outcome data (attrition bias) 
 Subjective outcomes Low risk Quote from publication: "one patient in the subtotal resection group... refused to come for evaluation after the first two post operative check ups"
Comment: one patient lost to follow‐up out of 44; all other outcomes reported
Selective reporting (reporting bias) High risk Comment: postoperative thyroid function (recurrent hyperthyroidism) was measured but not reported; mortality not reported
Other bias Low risk Comment: none identified